Keep you informed

Welcome to the Galenicum Axium news section. In this site, we will inform you about the latest updates of the company together with the most relevant product updates.

In Galenicum Axium, we are committed to our customers and partners, and we want to keep you informed with all the latest achievements of the company and the projects we are working on.

Visit us at CPhI Milano 2021

CPhI 2021 Milano

Galenicum will be exhibiting at the CPhI Worldwide 2021 in Milan from November 9th to 11th.

We have already booked slots with most of our partners. However, if you still do not have an appointment but would like to discuss potential business opportunities, come and meet us at Hall 1 (FDF), Stand F31. We are very excited to meet you in person after such a long time!

Read more

Thanks for reaching out. We will get back to you as soon as possible.

RESTRICTED ACCESS

The information contained in this section is aimed at the healthcare professional of the Pharmaceutical Industry, therefore, specialized training is required for its correct interpretation.

The products mentioned may have a different authorized data sheet in each country.

If you click the "accept" button, you are expressing your willingness to access the information explicitly intended for healthcare professionals.

DABIGAMAX

DEVELOPMENT OF THE FIRST GENERIC PHARMACEUTICAL SPECIALTY WITH DABIGATRAN. Decision EMC/2755/2017, dated November 20, (DOGC núm. 7508 of 30/11/2017) regarding the call for NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT (file number RD17-1-0006). This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIÓ.